Correlation Engine 2.0
Clear Search sequence regions

  • analysis cohort (1)
  • cancers (3)
  • cell cycle (1)
  • endometrium (1)
  • human (3)
  • layer (1)
  • LH receptor (1)
  • LH- R (5)
  • liver (1)
  • masses (2)
  • OGP (1)
  • ovary (1)
  • receptor (1)
  • system develop (1)
  • uteri (2)
  • uterus (2)
  • xenobiotics (1)
  • Sizes of these terms reflect their relevance to your search.

    The receptor for the luteinizing hormone (LH-R) is aberrantly over expressed in cancers of the reproductive system. To uncover whether LH-R over expression has a causative role in cancer, we generated a transgenic (TG) mouse which overexpresses the human LH-R (hLH-R) in the female reproductive tract, under the control of the oviduct-specific glycoprotein (OGP) mouse promoter (mogp-1). The transgene was highly expressed in the uterus, ovary and liver, but only in the uterus morphological and molecular alterations (increased proliferation and trans-differentiation in the endometrial layer) were detected. A transcriptomic analysis on the uteri of young TG mice showed an up regulation of genes involved in cell cycle control and a down regulation of genes related to the immune system and the metabolism of xenobiotics. Aged TG females developed tumor masses in the uteri, which resembled an Endometrial Cancer (EC). Microarray and immunohistochemistry data indicated the deregulation of signaling pathways which are known to be altered in human ECs. The analysis of a cohort of 126 human ECs showed that LH-R overexpression is associated with early-stage tumors. Overall, our data led support to conclude that LH-R overexpression may directly contribute to trigger the neoplastic transformation of the endometrium.


    Tiziano Lottini, Jessica Iorio, Elena Lastraioli, Laura Carraresi, Claudia Duranti, Cesare Sala, Miriam Armenio, Ivo Noci, Serena Pillozzi, Annarosa Arcangeli. Transgenic mice overexpressing the LH receptor in the female reproductive system spontaneously develop endometrial tumour masses. Scientific reports. 2021 Apr 23;11(1):8847

    PMID: 33893331

    View Full Text